Archives

by in
Entry Author Date Location
ImmunoGen Grabs $84M 05/20/11 Boston
SeaGen Ends March With $456M Cash 05/05/11 Seattle
Dyax, FivePrime Cut Antibody Deal 04/26/11 Boston
Genmab Expands SeaGen Alliance 04/19/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones 02/09/11 National
Secretive Biotech Arsanis Raises $9.6M 02/08/11 Boston
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug 02/02/11 Seattle
Scripps President Richard Lerner To Step Down, Be Replaced by Berkeley Chemist, Sources Say 01/31/11 San Diego
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars 01/28/11 National
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market 01/14/11 Seattle
Entrega Emerges From Enlight 01/10/11 Boston
Xoma Nabs $35M Upfront Deal 01/04/11 San Francisco
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Montgomery Joins Alder Board 11/01/10 Seattle
PacBio’s $200M IPO, Ablexis’ 5-Way Big Pharma Deal, Codexis Morphs Into $100M Business, & More Bay Area Life Sciences News 10/29/10 San Francisco
Ablexis Cuts Deal With Pfizer, Four Other Pharmas, For Antibody Drug Discovery Tool 10/26/10 San Francisco
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
ImmunoGen Gets $45M Upfront From Novartis To Make Souped Up Antibodies For Cancer 10/11/10 Boston
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
Page 2 of 4 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.